Comparison of Different Dose of Anti-T Lymphocyte Globulin (ATLG) in Haploidentical HSCT for GVHD Prophylaxis
Clinical trial NCT06525519 · UNKNOWN
Trial details
- NCT number
- NCT06525519
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2025-07-31
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.